ATORVASTATIN CALCIUM
- Product NDC
- 50090-6057
- 11-digit product format
- 500906057
- Labeler code
- 50090
- Product ID
- 50090-6057_6127c13c-d9cc-46b7-883d-ebd3df07cee9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA207687
- Marketing category
- ANDA
- Marketing start
- 2018-08-06
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 80 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6057-0 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 7 |
| 50090-6057-1 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6057 | ATORVASTATIN CALCIUM TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Legacy NDC, 2 package rows | 20220827_c4ec475d-8407-419c-b5e3-6b8dac17a79e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-6057-0 | 50090605700 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-6057-0) | 2022-08-25 | 0000-00-00 | No | No | Current |
| 50090-6057-1 | 50090605701 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-6057-1) | 2022-08-25 | 0000-00-00 | No | No | Current |